With over 30 years of experience in the industry, Rupert will be driving Expereo’s global customer-centric marketing strategy AMSTERDAM, Netherlands, Aug. 01, 2022 (GLOBE NEWSWIRE) — Expereo, the world’s leading provider of Global Internet, Cloud Access Optimization, SASE and SD-WAN
Neeyamo demonstrates its commitment to cloud security and data privacy by achieving ISO 27017 and ISO 27018 certifications. LOS GATOS, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) — Neeyamo, a leading provider of global payroll and EOR services, is pleased to
NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) — Webull Corporation (“Webull”), the owner of the popular Webull trading platform, today announced a promotional campaign to officially launch its Singapore business and entry into the Asia-Pacific region. Through Webull Securities (Singapore)
Pictured: Casa MOKE, Saint-Tropez EV Technology Group’s strategic partner MOKE International opens the doors of new ‘Casa MOKE’ flagship store in Saint-Tropez New MOKE website launches offering customers in the UK and Europe a personalised MOKE experience online, with cars
Both firms gain added proficiency in Salesforce Field Service, Revenue Cloud, CPQ, and Billing. Diabsolut Acquires Emelar Consulting Group MONTREAL, Aug. 01, 2022 (GLOBE NEWSWIRE) — Salesforce expert and innovative cloud solution provider Diabsolut announced that they have acquired Emelar
Firm Appoints Luiz Gustavo Aranha, CEO of RSG Brasil Headhunters, as Partner. N2Growth Logo PHILADELPHIA, Aug. 01, 2022 (GLOBE NEWSWIRE) — N2Growth Inc., a global leadership consulting and executive search firm, announced today its expansion to Brazil with the appointment
AOP Health signed an agreement with Leukos Biotech for the further development of a newly discovered chemical substance. With this agreement AOP Health expands the hemato-oncology research area even further and provides additional treatment options for certain leukemia patients in
WALTHAM, Mass and SHANGHAI, China, July 31, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies for patients in need around the world, announced that it